1.
Andarawi MO, Otifi H, Hassan H, Yousif AA, Mustafa SA, Elsiddig SA, et al. Exploring the efficacy of AMACR, ERG, and AR immunostains in prostatic adenocarcinoma and their association with novel grade groups. Eur J Histochem [Internet]. 2025 Feb. 11 [cited 2025 Feb. 20];69(1). Available from: https://www.ejh.it/index.php/ejh/article/view/4172